Screenshot of the official website of the State Food and Drug Administration According to the official website of the State Food and drug administration, the State Food and Drug Administration recently issued an announcement to cancel the registration certificates of 8 varieties of drugs such as Xiaoer fenamin granules. Article 83 of the drug administration law of the people's Republic of China stipulates that, after evaluation, the drug registration certificate shall be cancelled for drugs with uncertain curative effect, serious adverse reactions or endangering human health for other reasons. According to the announcement, the State Food and Drug Administration organized the post marketing evaluation of 8 varieties, including Xiaoer fenankamin granules, amfeika tablets, compound aminopyrine theophylline tablets, amlinfenka capsules, amcamin tablets, Butylated Hydroxy Acid Cream, Xiaoer compound aspirin tablets and amfeigamin tablets. After evaluation, the State Food and Drug Administration decided to stop the production, sales and use of the above eight varieties in China from now on, and cancel the drug registration certificate. The holder of the drug marketing license shall be responsible for recalling the products that have been sold on the market. The recalled products shall be destroyed under the supervision of the local provincial drug regulatory department or other harmless treatment measures shall be taken according to law. The reporter learned that the above eight varieties of drugs involve a number of pharmaceutical enterprises. Xiaoer fenamin granule involves the most pharmaceutical enterprises, with 37 relevant approval numbers. (outlook new era)